- Home
- MHK vs RGEN Comparison
MHK vs RGEN Comparison
Compare MHK & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MHK
- RGEN
- Stock Information
- Founded
- MHK 1988
- RGEN 1981
- Country
- MHK United States
- RGEN United States
- Employees
- MHK N/A
- RGEN N/A
- Industry
- MHK Home Furnishings
- RGEN Medical/Dental Instruments
- Sector
- MHK Consumer Discretionary
- RGEN Health Care
- Exchange
- MHK Nasdaq
- RGEN Nasdaq
- Market Cap
- MHK 7.2B
- RGEN 7.1B
- IPO Year
- MHK 1992
- RGEN N/A
- Fundamental
- Price
- MHK $102.69
- RGEN $130.00
- Analyst Decision
- MHK Buy
- RGEN Buy
- Analyst Count
- MHK 13
- RGEN 12
- Target Price
- MHK $145.00
- RGEN $175.56
- AVG Volume (30 Days)
- MHK 863.6K
- RGEN 951.5K
- Earning Date
- MHK 05-01-2025
- RGEN 04-29-2025
- Dividend Yield
- MHK N/A
- RGEN N/A
- EPS Growth
- MHK N/A
- RGEN N/A
- EPS
- MHK 8.14
- RGEN N/A
- Revenue
- MHK $10,836,900,000.00
- RGEN $634,439,000.00
- Revenue This Year
- MHK $0.23
- RGEN $12.29
- Revenue Next Year
- MHK $3.29
- RGEN $15.20
- P/E Ratio
- MHK $12.62
- RGEN N/A
- Revenue Growth
- MHK N/A
- RGEN 0.33
- 52 Week Low
- MHK $96.24
- RGEN $102.97
- 52 Week High
- MHK $164.29
- RGEN $182.52
- Technical
- Relative Strength Index (RSI)
- MHK 40.71
- RGEN 48.60
- Support Level
- MHK $99.87
- RGEN $105.06
- Resistance Level
- MHK $107.40
- RGEN $135.81
- Average True Range (ATR)
- MHK 5.78
- RGEN 9.95
- MACD
- MHK -0.50
- RGEN 1.83
- Stochastic Oscillator
- MHK 30.64
- RGEN 82.31
About MHK Mohawk Industries Inc.
Mohawk Industries Inc manufactures a wide range of flooring products, including carpets, rugs, ceramic tile, laminate, wood, luxury vinyl tile, and vinyl flooring. Its operating segments include Global Ceramic, Flooring North America, and Flooring Rest of the World. The company generates maximum revenue from the Global Ceramic segment. Geographically, it derives a majority of its revenue from the United States, while it also operates in Latin America, Europe and Others.
About RGEN Repligen Corporation
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.